Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,019,000 | 1,257,100 | 1,079,800 | 941,900 | 1,065,600 |
| Marketable Securities | 1,207,300 | 1,066,900 | 722,500 | 484,100 | 652,400 |
| Receivables | 1,506,000 | 1,400,300 | 2,252,900 | 2,067,000 | 1,484,000 |
| Inventories | 1,110,800 | 1,067,800 | 1,233,700 | 1,167,600 | 1,165,400 |
| Other current assets | 592,600 | 592,700 | 350,900 | 342,700 | 339,500 |
| TOTAL | $5,435,700 | $5,384,800 | $5,639,800 | $5,003,300 | $4,706,900 |
| Non-Current Assets | |||||
| PPE Net | 3,893,700 | 3,816,400 | 4,332,800 | 4,041,800 | 4,027,000 |
| Investments And Advances | 640,300 | 601,400 | 677,700 | 972,700 | 1,169,900 |
| Other Non-Current Assets | 1,306,300 | 1,298,800 | 1,188,500 | 1,149,400 | 1,199,600 |
| TOTAL | $5,840,300 | $5,716,600 | $6,199,000 | $6,163,900 | $6,396,500 |
| Total Assets | $9,724,000 | $9,590,100 | $10,130,400 | $9,555,100 | $9,467,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 2,800 | 0 |
| Accounts payable and accrued liabilities | 381,300 | 456,400 | 437,400 | 446,100 | 440,200 |
| Accrued Expenses | 334,700 | 332,900 | 309,800 | 318,700 | 270,900 |
| Other current liabilities | 720,700 | 779,900 | 797,100 | 897,900 | 674,100 |
| TOTAL | $3,616,400 | $3,217,400 | $3,224,000 | $3,158,200 | $3,046,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 573,600 | 571,300 | 591,600 | 581,000 | 579,800 |
| Other Non-Current Liabilities | 940,900 | 935,900 | 482,800 | 455,800 | 452,100 |
| TOTAL | $1,655,300 | $1,654,100 | $1,436,000 | $1,362,600 | $1,358,200 |
| Total Liabilities | $5,236,600 | $4,871,500 | $4,626,200 | $4,488,300 | $4,370,000 |
| Shareholders' Equity | |||||
| Common Shares | 33,700 | 33,700 | 33,600 | 33,500 | 33,400 |
| Retained earnings | 5,312,600 | 5,119,300 | 5,225,100 | 4,927,900 | 4,968,000 |
| Other shareholders' equity | -12,100 | 45,700 | 338,900 | 149,200 | 146,200 |
| TOTAL | $4,452,300 | $4,718,600 | $5,470,400 | $5,034,300 | $5,063,300 |
| Total Liabilities And Equity | $9,688,900 | $9,590,100 | $10,096,600 | $9,522,600 | $9,433,300 |